Otsuka’s Taiho Pharmaceutical is paying $400 million upfront to acquire Switzerland’s Araris Biotech and its antibody-drug ...

US-based biotechnology company Seismic Therapeutic has dosed the initial cohort of healthy participants in a randomised Phase ...

Taiho Pharmaceutical Co., Ltd.Araris Biotech AGTaiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris ...

The findings, led by researchers from the Institute of Modern Physics (IMP) of the Chinese Academy of Sciences and their ...

New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...

Each time a new wonder drug or superfood pops on the market, I’m skeptical. That didn’t keep me from ordering a certain brand ...

Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today announced that the company will present data on sevasemten, an investigational orally administered ...

TeleRare Healthtm launched a partnership today with a leading community health system in Maryland, with a focus on expanding patient access to genetic testing, diagnosis, and knowledgeable care for ...

Plans to develop S-1117 for treatment of wide array of IgG autoantibody-driven diseases, such as myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and immune thrombocytopenia ...

Among 5602 participants assessed at the start of the first year of the study, the seroprevalence of IgG as assessed with ELISA was 42.8% (95% CI, 35.8 to 50.2). IgG seropositivity at the beginning ...